These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11598337)

  • 1. Neuroleptic malignant-like syndrome and acute hepatitis during tolcapone and clozapine medication.
    Blum MW; Siegel AM; Meier R; Hess K
    Eur Neurol; 2001; 46(3):158-60. PubMed ID: 11598337
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
    Iwuagwu CU; Riley D; Bonoma RA
    Am J Med; 2000 Apr; 108(6):517-8. PubMed ID: 10866587
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 4. NMS after clozapine initiation.
    Skarpathiotakis M; Westreich N
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolcapone and fulminant hepatitis.
    Assal F; Spahr L; Hadengue A; Rubbia-Brandt L; Burkhard PR
    Lancet; 1998 Sep; 352(9132):958. PubMed ID: 9752821
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful clozapine rechallenge following prior intolerance to clozapine.
    Cohen SA
    J Clin Psychiatry; 1994 Nov; 55(11):498-9. PubMed ID: 7989287
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic rechallenge after neuroleptic malignant syndrome.
    Giacardi-Paty M; Bottai T; Pujalte D; Lainey E; Petit P
    Br J Psychiatry; 1993 Jul; 163():121-2. PubMed ID: 8102585
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome.
    Brown TM
    Psychosomatics; 1999; 40(6):518-20. PubMed ID: 10581982
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine-associated neuroleptic malignant syndrome.
    Baciewicz AM; Chandra R; Whelan P
    Ann Intern Med; 2002 Sep; 137(5 Part 1):374. PubMed ID: 12204041
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group.
    Mov Disord; 1999 Jan; 14(1):38-44. PubMed ID: 9918342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenylalanine/carbidopa and selegiline.
    Davis TL; Roznoski M; Burns RS
    Mov Disord; 1995 May; 10(3):349-51. PubMed ID: 7651456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterations.
    Spahr L; Rubbia-Brandt L; Burkhard PR; Assal F; Hadengue A
    Dig Dis Sci; 2000 Sep; 45(9):1881-4. PubMed ID: 11052337
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome associated with clozapine use.
    Anderson ES; Powers PS
    J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients. Tolcapone De Novo Study Group.
    Hauser RA; Molho E; Shale H; Pedder S; Dorflinger EE
    Mov Disord; 1998 Jul; 13(4):643-7. PubMed ID: 9686768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome and clozapine monotherapy.
    Chatterton R; Cardy S; Schramm TM
    Aust N Z J Psychiatry; 1996 Oct; 30(5):692-3. PubMed ID: 8902179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Lannon MC; Friedman JH; Abbott BP
    Mov Disord; 2000 May; 15(3):579-81. PubMed ID: 10830427
    [No Abstract]   [Full Text] [Related]  

  • 18. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
    Sachdev P; Kruk J; Kneebone M; Kissane D
    J Clin Psychopharmacol; 1995 Oct; 15(5):365-71. PubMed ID: 8830069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case Report: Atypical Neuroleptic Malignant Syndrome on Clozapine and Mood Stabilizers.
    Amador EC; Kassam A; Hopp C; Cunningham EA
    J Clin Psychopharmacol; 2019; 39(5):518-519. PubMed ID: 31425460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.